-
MedCity Influencers, Medical Devices
Former Medtronic CEO William Hawkins reflects on MDT
They gave him a sword and he handed them the world. When William Hawkins officially […]
-
MedCity Influencers, Medical Devices, Policy
Committee urges investigation into security of wireless medical devices
The recent report of a computer security expert who hacked his own insulin pump got […]
-
In-home care positioned to play a key role in the consumerization of healthcare
Eddie Peloke, CEO of Workpath, spoke to why in-home care can drive the next stage of this industry-wide movement
-
MedCity Influencers, Medical Devices
Mobile medical apps to be topic of FDA workshop on agency’s guidance
The FDA planned a public workshop for mid-September to discuss the recently released draft guidance […]
-
MedCity Influencers, Medical Devices
Jacksonville offers $1.6M in aid for Medtronic to create jobs in Florida
Medtronic Inc. (NYSE:MDT) landed a $1.6 million aid package from the Jacksonville City Council, which […]
-
MedCity Influencers, Medical Devices, Policy
FDA tells ‘fallen angel’ medical devices to submit PMAs or be taken off market
The FDA set an August 23 date for a final rule for three “fallen angel” […]
-
MedCity Influencers, Medical Devices
BSX’s one-time largest shareholder Paulson & Co. sells all $15M in shares
Paulson & Co. Inc. is Boston Scientific Corp.’s (NYSE:BSX) largest shareholder no more, after liquidating […]
-
MedCity Influencers, Medical Devices
Japanese trial for Abbott dissolvable stent gets first patient
Abbott (NYSE:ABT) enrolled its first patients in a Japanese trial of the Absorb bioresorbable vascular […]
-
MedCity Influencers, Medical Devices
Cardiac rhythm management industry still in a slump
The cardiac rhythm management industry looks like it needs of a jolt of its own, […]
-
MedCity Influencers, Medical Devices
Benefit-risk determination for premarket applications outlined by FDA
The FDA released a new guidance yesterday detailing the agency’s process of making benefit-risk determinations […]
-
Improving health in one of the most complex and costly chronic conditions
Kidney care in the U.S. needs an overhaul. Changing today’s expensive, disconnected care model requires moving from volume to value.
Misha Palecek, Chief Transformation Officer, DaVita Kidney Care
-
MedCity Influencers, Medical Devices
FDA guidance on clinical trials aims to help device makers
The FDA took bold steps to outline expectations for medical device premarket submissions in the […]
-
MedCity Influencers, Medical Devices
Incontinence device from Medtronic tests well in clinical trials
Medtronic Inc. (NYSE:MDT) got a thumbs up for its InterStim sacral nerve stimulation product’s clinical […]
-
MedCity Influencers, Medical Devices
FDA’s 510(k) program unfixable, New England Journal of Medicine agrees
The Institute of Medicine was right to dub the FDA’s 510(k) medical device program unfixable, […]
-
US healthcare reform wins one, loses one
In the latest volley in the individual insurance mandate lawsuits, a Ninth Circuit court dismissed […]
-
MedCity Influencers, Medical Devices
Boston Scientific takes a beating amid stock market chaos
Shares of Boston Scientific Corp. (NYSE:BSX) traded at unusually high volumes for two straight weeks […]
-
MedCity Influencers, Medical Devices
Diabetes, obesity device company GI Dynamics opens Australian IPO
GI Dynamics officials are still on the down low about their IPO down under, but […]



